Is Forte Biosciences FBRX stock respecting technical levels Q4 2025 Earnings Fall Short XHG XChange reports narrower than expected Q4 2019 loss shares rise 392 percent on upbeat investor sentiment NOM Nuveen latest quarterly earnings report carries no consensus comparable metrics as management reaffirms its muni portfolio strategy